Innate endogenous adjuvants prime to desirable immune responses via mucosal routes.
10.1007/s13238-014-0125-1
- Author:
Xiaoguang WANG
1
;
Delong MENG
Author Information
1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China, wxg402@hotmail.com.
- Publication Type:Journal Article
- MeSH:
Adjuvants, Immunologic;
Animals;
Humans;
Immunity, Innate;
immunology;
Immunity, Mucosal;
immunology;
Vaccines;
administration & dosage;
immunology
- From:
Protein & Cell
2015;6(3):170-184
- CountryChina
- Language:English
-
Abstract:
Vaccination is an effective strategy to prevent infectious or immune related diseases, which has made remarkable contribution in human history. Recently increasing attentions have been paid to mucosal vaccination due to its multiple advantages over conventional ways. Subunit or peptide antigens are more reasonable immunogens for mucosal vaccination than live or attenuated pathogens, however adjuvants are required to augment the immune responses. Many mucosal adjuvants have been developed to prime desirable immune responses to different etiologies. Compared with pathogen derived adjuvants, innate endogenous molecules incorporated into mucosal vaccines demonstrate prominent adjuvanticity and safety. Nowadays, cytokines are broadly used as mucosal adjuvants for participation of signal transduction of immune responses, activation of innate immunity and polarization of adaptive immunity. Desired immune responses are promptly and efficaciously primed on basis of specific interactions between cytokines and corresponding receptors. In addition, some other innate molecules are also identified as potent mucosal adjuvants. This review focuses on innate endogenous mucosal adjuvants, hoping to shed light on the development of mucosal vaccines.
